Search

everythinglearnresearchcommunity

for

Search:↓

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Valproic acid treatment may cause hair loss due to reduced biotinidase activity.

Valproic acid does not change biotinidase enzyme activity in children's blood.

The treatment with valproate, acetylcarnitine, folic acid, and vitamin B12 may improve muscle strength in children with SMA without significant side effects.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Divalproex sodium significantly improved headaches in two-thirds of patients.

A patient with pemphigus vulgaris improved significantly after treatment for an additional viral skin infection.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

Indinavir can cause hair loss and other skin problems.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

High-dose IV iron is safe and effective for treating anaemia in IBD patients.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Five FDA-approved drugs may help block COVID-19 virus entry.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

MVP treatment is effective and safe for recurrent breast cancer.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Topical ruxolitinib quickly improves non-segmental vitiligo.

Research on HIV-1 capsid inhibitors has progressed significantly, with the U.S. leading in contributions.

Itraconazole may cause low platelet and white blood cell counts.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Biotin may effectively treat hair loss caused by valproate medication.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.